Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

AACR 2009: Anti-angiogenics to tackle brain and prostate tumours

Prof Gabriele Bergers - University of California, San Francisco
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours ( Prof Gabriele Bergers - University of California, San Francisco )
14 May 2009

AACR 2009: MicroRNA profiles of colorectal adenocarcinomas

Dr Upender Manne - Associate Professor of Pathology, Birmingham School of Medicine, University of Albama, USA
AACR 2009: MicroRNA profiles of colorectal adenocarcinomas ( Dr Upender Manne - Associate Professor of Pathology, Birmingham School of Medicine, University of Albama, USA )
7 May 2009

Epigenetics of myelodysplastic syndromes

Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France
Epigenetics of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009

Innovation in the treatment of myelodysplastic syndromes

Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France
Innovation in the treatment of myelodysplastic syndromes ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009

Myelodysplastic syndromes (MDS)

Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France
Myelodysplastic syndromes (MDS) ( Prof Pierre Fenaux - Service d'Hématologie Clinique, Avicenne Hospital / Université Paris, France )
6 May 2009

AACR 2009: Identification of the EGFRvIII Mutation in Glioblastoma

Prof. Donald O'Rourke - Associate Professor of Neurosurgery, University of Pennsylvania
AACR 2009: Identification of the EGFRvIII Mutation in Glioblastoma ( Prof. Donald O'Rourke - Associate Professor of Neurosurgery, University of Pennsylvania )
1 May 2009

AACR 2009: Genetics of pleuropulmonary blastoma

Dr Dana Ashley Hill - Chief of Anatomic Pathology, Children's National Medical Center, USA
AACR 2009: Genetics of pleuropulmonary blastoma ( Dr Dana Ashley Hill - Chief of Anatomic Pathology, Children's National Medical Center, USA )
1 May 2009

AACR 2009: Ovarian cancer biomarkers

Prof. Daniel Cramer - Dept Obstetrics and Gynaecology, Brigham and Women's Hospital, Harvard Medical School, USA
AACR 2009: Ovarian cancer biomarkers ( Prof. Daniel Cramer - Dept Obstetrics and Gynaecology, Brigham and Women's Hospital, Harvard Medical School, USA )
1 May 2009

AACR 2009: Genetic influences in response to EGFR for metastatic colorectal cancer

Frederica Di Nicolantonio - Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Turin Medical School, Italy
AACR 2009: Genetic influences in response to EGFR for metastatic colorectal cancer ( Frederica Di Nicolantonio - Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Turin Medical School, Italy )
1 May 2009

AACR 2009: Molecular profiling of tumours to find potential targets and treatments for refractory cancers

Dr Daniel Von Hoff - Chief Scientific Officer, Scottsdale Healthcare and U.S. Oncology Research
AACR 2009: Molecular profiling of tumours to find potential targets and treatments for refractory cancers ( Dr Daniel Von Hoff - Chief Scientific Officer, Scottsdale Healthcare and U.S. Oncology Research )
1 May 2009

AACR 2009: Preclinical Analysis of Combined PI3K and MEK Inhibition as a Strategy for the Treatment of Cancer

Dr Lori Friedman - Director, Cancer Signalling and Translational Oncology, Genentech
AACR 2009: Preclinical Analysis of Combined PI3K and MEK Inhibition as a Strategy for the Treatment of Cancer ( Dr Lori Friedman - Director, Cancer Signalling and Translational Oncology, Genentech )
30 Apr 2009

AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL) with Poor Outcome: A New Therapeutic Target in Resistant Disease

Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hospital
AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL) with Poor Outcome: A New Therapeutic Target in Resistant Disease ( Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hospital )
30 Apr 2009

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation